SCHEMBL17464946

SCHEMBL17464946

Cc1cc(C)c(-c2ncc(Br)c(=O)n2Cc2ccc(Cl)cc2)c(C)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RX3 P56373 4/20 0.48
▸ KDM4E B2RXH2 3/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ GAA P10253 1/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ HPGD P15428 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ POLB P06746 2/20 0.38
▸ MAPT P10636 2/20 0.38
▸ TP53 P04637 1/20 0.38
▸ THRB P10828 1/20 0.38
▸ BRD4 O60885 3/20 0.38
▸ APAF1 O14727 1/20 0.38
▸ CCNC P24863 1/20 0.37
▸ CDK8 P49336 1/20 0.37
▸ ITGB2 P05107 1/20 0.36
▸ ICAM1 P05362 1/20 0.36
▸ ITGAL P20701 1/20 0.36
▸ RGS4 P49798 1/20 0.36
▸ RGS8 P57771 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17464948 0.85 P2RX3 (0.47) P2RX3KDM4EALDH1A1GAASMN1; SMN2
SCHEMBL15215746 0.80 ALDH1A1 (0.56) P2RX3KDM4EALDH1A1GAASMN1; SMN2
SCHEMBL17464947 0.78 KDM4E (0.48) P2RX3KDM4EALDH1A1GAASMN1; SMN2
SCHEMBL15180941 0.77 P2RX3 (0.47) P2RX3KDM4EALDH1A1GAASMN1; SMN2
SCHEMBL15015960 0.75 P2RX3 (0.47) P2RX3KDM4EALDH1A1GAAHPGD
SCHEMBL17879620 0.71 P2RX3 (0.49) P2RX3KDM4EALDH1A1GAAHPGD
SCHEMBL7819044 0.66 HTT (0.46) P2RX3ALDH1A1SMN1; SMN2HPGDHSD17B10
SCHEMBL30408739 0.65 CCNC (0.48) P2RX3KDM4EALDH1A1GAASMN1; SMN2
SCHEMBL3330739 0.64 KDM4E (0.45) P2RX3KDM4EALDH1A1GAASMN1; SMN2
SCHEMBL23555763 0.64 ALDH1A1 (0.54) P2RX3KDM4EALDH1A1GAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9550763-B2 Heterocyclic ring and carbocyclic derivative SHIONOGI & CO., LTD. (JP) 2017-01-24 — — US disclosed
US-20160024072-A1 Heterocyclic Ring and Carbocyclic Derivative SHIONOGI & CO., LTD. (JP) 2016-01-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160024072-A1 Heterocyclic Ring and Carbocyclic Derivative P2RX3, P2RX7, P2RX2 P2RX3 1/4885KDM4E 3118/4885ALDH1A1 2515/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback